RNAC
Cartesian Therapeutics Inc.
$6.14
-$0.14(-2.23%)
40
Overall
40
Value
40
Tech
--
Quality
Market Cap
$166.48M
Volume
118.63K
52W Range
$5.60 - $15.57
Target Price
$35.57
Company Overview
| Mkt Cap | $166.48M | Price | $6.14 |
| Volume | 118.63K | Change | -2.23% |
| P/E Ratio | -2.2 | Open | $6.55 |
| Revenue | $38.3M | Prev Close | $6.28 |
| Net Income | $-77.4M | 52W Range | $5.60 - $15.57 |
| Div Yield | N/A | Target | $35.57 |
| Overall | 40 | Value | 40 |
| Quality | -- | Technical | 40 |
No chart data available
Latest News
Cartesian Therapeutics Announces Board Member Murat Kalayoglu Resignation
TipRanks Auto-Generated Newsdesk•9 days ago
RNAC’s Descartes-08 Moves Toward Phase 2 in Rare Muscle Disease: What Investors Should Watch
TipRanks Clinical-Trials-Auto-Generated Newsdesk•a month ago
Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS), Design Therapeutics (DSGN) and Cartesian Therapeutics (RNAC)
Christine Brown•a month ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
Catie Powers•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $6.14 | -2.2% | 118.63K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW